PT Merck Tbk (MERK.JK)
IDR 3580.0
(0.85%)
IDR 3580.0
(0.85%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 239.49 Billion IDR | -7.52% |
| 2022 | 272.51 Billion IDR | 23.29% |
| 2021 | 231.35 Billion IDR | 68.13% |
| 2020 | 141.26 Billion IDR | -7.71% |
| 2019 | 132.75 Billion IDR | 151.62% |
| 2018 | 55.27 Billion IDR | -75.39% |
| 2017 | 43.97 Billion IDR | -3.16% |
| 2016 | 228.89 Billion IDR | 11.41% |
| 2015 | 197.63 Billion IDR | -5.55% |
| 2014 | 209.3 Billion IDR | -13.13% |
| 2013 | 200.71 Billion IDR | 58.43% |
| 2012 | 152.33 Billion IDR | -16.19% |
| 2011 | 179.99 Billion IDR | 17.19% |
| 2010 | 154.93 Billion IDR | -26.45% |
| 2009 | 217.45 Billion IDR | 46.19% |
| 2008 | 143.29 Billion IDR | 12.01% |
| 2007 | 128.77 Billion IDR | 3.6% |
| 2006 | 124.02 Billion IDR | 46.48% |
| 2005 | 84.53 Billion IDR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q3 | 39.7 Billion IDR | 39.64% |
| 2024 Q2 | 26.73 Billion IDR | -13.49% |
| 2024 Q1 | 35.04 Billion IDR | -15.38% |
| 2023 FY | - IDR | -7.52% |
| 2023 Q4 | 44.23 Billion IDR | -16.23% |
| 2023 Q3 | 52.8 Billion IDR | -18.13% |
| 2023 Q2 | 64.49 Billion IDR | 2.91% |
| 2023 Q1 | 62.67 Billion IDR | 36.12% |
| 2022 Q3 | 39.91 Billion IDR | -49.48% |
| 2022 Q2 | 79 Billion IDR | -7.82% |
| 2022 Q1 | 85.7 Billion IDR | 120.78% |
| 2022 FY | - IDR | 23.29% |
| 2022 Q4 | 46.04 Billion IDR | 15.35% |
| 2021 FY | - IDR | 68.13% |
| 2021 Q1 | 72.08 Billion IDR | 103.55% |
| 2021 Q2 | 41.25 Billion IDR | -42.77% |
| 2021 Q3 | 51.16 Billion IDR | 24.01% |
| 2021 Q4 | 38.81 Billion IDR | -24.13% |
| 2020 FY | - IDR | -7.71% |
| 2020 Q2 | 6.57 Billion IDR | -84.49% |
| 2020 Q4 | 35.41 Billion IDR | -3.13% |
| 2020 Q1 | 42.37 Billion IDR | -55.81% |
| 2020 Q3 | 36.55 Billion IDR | 456.06% |
| 2019 FY | - IDR | 151.62% |
| 2019 Q1 | 20.14 Billion IDR | 114.36% |
| 2019 Q2 | 450.62 Million IDR | -97.76% |
| 2019 Q3 | 18.51 Billion IDR | 4009.31% |
| 2019 Q4 | 95.89 Billion IDR | 417.88% |
| 2018 Q3 | 67.42 Billion IDR | 23.92% |
| 2018 Q2 | 54.4 Billion IDR | -24.1% |
| 2018 FY | - IDR | -75.39% |
| 2018 Q1 | 71.68 Billion IDR | 2143.3% |
| 2018 Q4 | -140.28 Billion IDR | -308.06% |
| 2017 Q2 | 49.1 Billion IDR | -45.08% |
| 2017 FY | - IDR | -3.16% |
| 2017 Q4 | 3.19 Billion IDR | -95.43% |
| 2017 Q3 | 69.85 Billion IDR | 42.25% |
| 2017 Q1 | 89.41 Billion IDR | 92.0% |
| 2016 FY | - IDR | 11.41% |
| 2016 Q1 | 81.59 Billion IDR | 152.74% |
| 2016 Q2 | 50.8 Billion IDR | -37.73% |
| 2016 Q3 | 39.49 Billion IDR | -22.28% |
| 2016 Q4 | 46.57 Billion IDR | 17.93% |
| 2015 Q1 | 67.45 Billion IDR | 290.23% |
| 2015 Q2 | 53.23 Billion IDR | -21.08% |
| 2015 Q3 | 43.12 Billion IDR | -18.98% |
| 2015 Q4 | 32.28 Billion IDR | -25.14% |
| 2015 FY | - IDR | -5.55% |
| 2014 FY | - IDR | -13.13% |
| 2014 Q1 | 82.86 Billion IDR | 189.22% |
| 2014 Q2 | 53.32 Billion IDR | -35.64% |
| 2014 Q4 | 17.28 Billion IDR | -66.95% |
| 2014 Q3 | 52.3 Billion IDR | -1.92% |
| 2013 FY | - IDR | 58.43% |
| 2013 Q4 | 28.65 Billion IDR | -38.02% |
| 2013 Q3 | 46.22 Billion IDR | -7.04% |
| 2013 Q2 | 49.72 Billion IDR | -55.05% |
| 2013 Q1 | 110.62 Billion IDR | 1795.47% |
| 2012 Q2 | 53.78 Billion IDR | 7.65% |
| 2012 Q4 | 5.83 Billion IDR | -83.44% |
| 2012 FY | - IDR | -16.19% |
| 2012 Q1 | 49.96 Billion IDR | 4.12% |
| 2012 Q3 | 35.23 Billion IDR | -34.49% |
| 2011 FY | - IDR | 17.19% |
| 2011 Q3 | 45.68 Billion IDR | 66.57% |
| 2011 Q2 | 27.42 Billion IDR | -55.27% |
| 2011 Q1 | 61.3 Billion IDR | 76.69% |
| 2011 Q4 | 47.98 Billion IDR | 5.04% |
| 2010 Q4 | 34.69 Billion IDR | 0.0% |
| 2010 FY | - IDR | -26.45% |
| 2010 Q1 | 53.66 Billion IDR | -3.26% |
| 2009 FY | - IDR | 46.19% |
| 2009 Q4 | 55.47 Billion IDR | 0.0% |
| 2009 Q1 | 55.62 Billion IDR | 0.0% |
| 2008 FY | - IDR | 12.01% |
| 2007 FY | - IDR | 3.6% |
| 2006 FY | - IDR | 46.48% |
| 2005 FY | - IDR | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| PT Darya-Varia Laboratoria Tbk | 255.91 Billion IDR | 6.417% |
| PT Phapros, Tbk | 120.77 Billion IDR | -98.298% |
| PT Pyridam Farma Tbk | 60.69 Billion IDR | -294.568% |
| PT Industri Jamu dan Farmasi Sido Muncul Tbk | 1323.93 Billion IDR | 81.911% |
| PT Tempo Scan Pacific Tbk | 1997.6 Billion IDR | 88.011% |